Pyrazoloheteroaryls:: Novel p38α MAP kinase inhibiting scaffolds with oral activity

被引：79

作者：

Revesz, L ^{[1
]}

Blum, E ^{[1
]}

Di Padova, FE ^{[1
]}

Buhl, T ^{[1
]}

Feifel, R ^{[1
]}

Gram, H ^{[1
]}

Hiestand, P ^{[1
]}

Manning, U ^{[1
]}

Neumann, U ^{[1
]}

Rucklin, G ^{[1
]}

机构：

[1] Novartis Inst Biomed Res, Global Discovery Chem, CH-4002 Basel, Switzerland

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2006年 / 16卷 / 02期

关键词：

p38; inhibition; MAP kinase inhibition; rheumatoid arthriitis; antiarthritic; anti-inflammatory; collagen-induced arthritis; adjuvant-induced arthritis;

D O I：

10.1016/j.bmcl.2005.10.015

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A test library with three novel p38 alpha inhibitory scaffolds and a narrow set of substituents was prepared. Appropriate combination of substituent and scaffold generated potent p38 alpha inhibitors, for example, pyrazolo[3,4-b]pyridine 9, pyrazolo[3,4-d]pyrimidine 18a and pyrazolo[3,4-b]pyrazine 23b with potent in vivo activity upon oral administration in animal models of rheumatoid arthritis. (c) 2005 Elsevier Ltd. All rights reserved.

引用

页码：262 / 266

页数：5

共 50 条

[21] INHIBITION OF p38 MAP KINASE BY UTILIZING A NOVEL ALLOSTERIC BINDING SITE
Tong, L.
Pargellis, C.
Churchill, L.
Cirillo, P.
Gilmore, T.
Graham, A. G.
Grob, P. M.
Hickey, E. R.
Moss, N.
Pav, S.
Regan, J.
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2002, 58 : C231 - C231
[22] A novel lipid binding site formed by the MAP kinase insert in p38α
Diskin, Ron
Engelberg, David
Livnah, Oded
JOURNAL OF MOLECULAR BIOLOGY, 2008, 375 (01) : 70 - 79
[23] Synthesis and biological activity of quinolinone and dihydroquinolinone p38 MAP kinase inhibitors
Chen, Meng-Hsin
Fitzgerald, Patricia
Singh, Suresh B.
O'Neill, Edward A.
Schwartz, Cheryl D.
Thompson, Chris M.
O'Keefe, Stephen J.
Zaller, Dennis M.
Doherty, James B.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (06) : 2222 - 2226
[24] Discovery and design of novel benzimidazolone as inhibitors of p38 MAP kinase.
Hammach, A
Ralph, M
Corbo, F
Barbosa, A
Liu, PR
Soleymanzadeh, F
Goldberg, D
Sarko, C
Mckibben, B
Moss, N
Hao, MH
White, A
Qian, K
Pargellis, C
Kroe, R
Wildeson, J
Nelson, R
Fadra, T
Capolino, A
Kashem, M
Patnaude, L
Madwed, J
Torcellini, C
Kaplita, P
Farrel, T
Hu, HB
Yazdania, M
Kavanaugh, K
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U947 - U947
[25] 4-azaindoles: Novel inhibitors of p38 MAP kinase.
Trejo, A
Arzeno, H
Browner, M
Cheng, SA
Corner, DD
Dalrymple, S
Freire-Moar, J
Lim, J
Mcintosh, J
Miller, J
Myers, PL
Saunders, J
Sjogren, EB
Spellmyer, D
Warren, SD
Whiteley, PE
Zeng, L
Goldstein, DM
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U59 - U59
[26] Novel, potent and selective anilinoquinazoline and anilinopyrimidine inhibitors of p38 MAP kinase
Cumming, JG
McKenzie, CL
Bowden, SG
Campbell, D
Masters, DJ
Breed, J
Jewsbury, PJ
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (21) : 5389 - 5394
[27] Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site
Pargellis, C
Tong, L
Churchill, L
Cirillo, PF
Gilmore, T
Graham, AG
Grob, PM
Hickey, ER
Moss, N
Pav, S
Regan, J
NATURE STRUCTURAL BIOLOGY, 2002, 9 (04) : 268 - 272
[28] Regulation of p38 MAP kinase activity by preconditioning stimuli in cardiac myocytes
Nagarkatti, DS
Shaafi, RI
MOLECULAR BIOLOGY OF THE CELL, 1997, 8 : 1426 - 1426
[29] Design, synthesis, and SAR of a novel series of p38α MAP kinase inhibitors
Martin, Barrie P.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
[30] T cell activation signals upregulate p38 map kinase activity
Wang, L
Schafer, PH
Davis, JE
Wadsworth, SA
Siekierka, JJ
FASEB JOURNAL, 1997, 11 (09): : A1168 - A1168

← 1 2 3 4 5 →